Concepedia

Publication | Open Access

Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents

39

Citations

32

References

2022

Year

Abstract

Decreasing preference for high-caloric, high-fat foods is a powerful action of GLP-1R and dual GIPR/GLP-1R agonist therapeutics, which may contribute to the weight loss success of these drugs.

References

YearCitations

Page 1